Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 05/31/2021 (updated monthly) $1,346.4 (M)
Net Assets - Advisor ClassAs of 04/30/2021 (updated monthly) $206.4 (M)
P/E Ratio (12-mo Forward)As of 05/31/2021 (updated monthly) 14.28
P/B RatioAs of 05/31/2021 (updated monthly) 4.80

Positions As of 05/31/2021

Portfolio Details

Asset AllocationAs of 05/31/2021

[name] [value]
Equity 99.30%
Cash & Cash Equivalents 0.70%

Geographic BreakdownAs of 05/31/2021

[name] [value]
United States 92.64%
Denmark 2.22%
Canada 1.83%
Netherlands 1.18%
Switzerland 1.15%
Cash & Cash Equivalents 0.70%
United Kingdom 0.28%

sector breakdownAs of 05/31/2021

[name] [value]
Biotechnology 77.99%
Pharmaceuticals 12.73%
Life Sciences Tools & Services 5.64%
Diversified Capital Markets 1.69%
Other Diversified Financial Services 0.74%
Cash & Cash Equivalents 0.70%
Health Care Equipment 0.36%
Health Care Facilities 0.15%

TOP TEN HOLDINGSAs of 05/31/2021

41.98%
Other
0% 100%
[holdings-table-heading]
GILEAD SCIENCES INC 6.82%
AMGEN INC 5.63%
REGENERON PHARMACEUTICALS INC 5.16%
VERTEX PHARMACEUTICALS INC 4.78%
ILLUMINA INC 4.55%
HORIZON PHARMA PLC 3.65%
BIOGEN INC 2.94%
JAZZ PHARMACEUTICALS PLC 2.94%
MIRATI THERAPEUTICS INC 2.86%
NOVAVAX INC 2.65%